TOSO promotes β-cell proliferation and protects from apoptosis

被引:4
作者
Dharmadhikari, G. [1 ]
Muehle, M. [2 ]
Schulthess, F. T. [1 ,2 ]
Laue, S. [1 ]
Oberholzer, J. [3 ]
Pattou, F. [4 ]
Kerr-Conte, J. [4 ]
Maedler, K. [1 ]
机构
[1] Univ Bremen, Ctr Biomol Interact Bremen, Leobener Str NW2,Room B2080, D-28359 Bremen, Germany
[2] Univ Calif Los Angeles, Larry Hilolom Islet Res Ctr, Los Angeles, CA USA
[3] Univ Illinois, Div Transplantat, Chicago, IL USA
[4] Univ Lille Nord France, INSERM, Therapie Cellulaire Diabet, Lille, France
来源
MOLECULAR METABOLISM | 2012年 / 1卷 / 1-2期
基金
欧洲研究理事会;
关键词
TOSO; Fas; Islets; beta-cell proliferation; Diabetes; LIGAND-INDUCED APOPTOSIS; FAS LIGAND; PANCREATIC-ISLETS; B-CELLS; DEATH; RECEPTOR; EXPRESSION; MOUSE; INTERLEUKIN-1-BETA; TURNOVER;
D O I
10.1016/j.molmet.2012.08.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Decreased beta-cell mass reflects a shift from quiescence/proliferation into apoptosis, it plays a crucial role in the pathophysiology of diabetes. A major attempt to restore beta-cell mass and normoglycemia is to improve beta-cell survival. Here we show that switching off the Fas pathway using Fas apoptotic inhibitory protein (Faim/TOSO), which regulates apoptosis upstream of caspase 8, blocked (beta-cell apoptosis and increased proliferation in human islets. TOSO was clearly expressed in pancreatic beta-cells and down-regulated in T2DM. TOSO expression correlated with beta-cell turnover; at conditions of improved survival, TOSO was induced. In contrast, TOSO downregulation induced beta-cell apoptosis. Although TOSO overexpression resulted in a 3-fold induction of proliferation, proliferating 13 -cells showed a very limited capacity to undergo multiple rounds of replication. Our data suggest that TOSO is an important regulator of beta-cell turnover and switches beta-cell apoptosis into proliferation. 2012 Elsevier GmbH. Open access under CC-BY-NC-ND license.
引用
收藏
页码:70 / 78
页数:9
相关论文
共 48 条
  • [1] FAS ANTIGEN SIGNALS PROLIFERATION OF NORMAL HUMAN-DIPLOID FIBROBLAST AND ITS MECHANISM IS DIFFERENT FROM TUMOR-NECROSIS-FACTOR RECEPTOR
    AGGARWAL, BB
    SINGH, S
    LAPUSHIN, R
    TOTPAL, K
    [J]. FEBS LETTERS, 1995, 364 (01) : 5 - 8
  • [2] Transgenic expression of dominant-negative fas-associated death domain protein in β cells protects against fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice
    Allison, J
    Thomas, HE
    Catterall, T
    Kay, TWH
    Strasser, A
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (01) : 293 - 301
  • [3] Mechanisms of β cell death in diabetes:: A minor role for CD95
    Allison, J
    Strasser, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) : 13818 - 13822
  • [4] Ardestani A., 2011, J BIOL CHEM
  • [5] β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes
    Butler, AE
    Janson, J
    Bonner-Weir, S
    Ritzel, R
    Rizza, RA
    Butler, PC
    [J]. DIABETES, 2003, 52 (01) : 102 - 110
  • [6] The role of Fas in autoimmune diabetes
    Chervonsky, AV
    Wang, Y
    Wong, FS
    Visintin, I
    Flavell, RA
    Janeway, CA
    Matis, LA
    [J]. CELL, 1997, 89 (01) : 17 - 24
  • [7] CLARK A, 1988, DIABETES RES CLIN EX, V9, P151
  • [8] cFLIP protein prevents tumor necrosis factor-α-mediated induction of caspase-8-dependent apoptosis in insulin-secreting βTc-Tet cells
    Cottet, S
    Dupraz, P
    Hamburger, F
    Dolci, W
    Jaquet, M
    Thorens, B
    [J]. DIABETES, 2002, 51 (06) : 1805 - 1814
  • [9] Cytokine production by islets in health and diabetes: cellular origin, regulation and function
    Donath, Marc Y.
    Boeni-Schnetzler, Marianne
    Ellingsgaard, Helga
    Halban, Philippe A.
    Ehses, Jan A.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2010, 21 (05) : 261 - 267
  • [10] Inflammatory mediators and islet β-cell failure:: a link between type 1 and type 2 diabetes
    Donath, MY
    Storling, J
    Maedler, K
    Mandrup-Poulsen, T
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (08): : 455 - 470